November 4-7, 2018 in Washington, DC
at the Walter E. Convention Center

Visit us at booth 2115

Meet with our team of experts at Booth 2115 to learn about our latest products and services, and our complete portfolio for all stages of the drug manufacturing process, from research to industrial-scale production and quality control.

Our newest technologies will improve productivity, lower risks, reduce costs and ensure safety. Together, we are advancing pharmaceutical production to accelerate development of therapeutic drug for patients in need.

Visit the Event Website

Mark your calendar! You don’t want to miss these presentations:

• Polyvinyl alcohol (PVA) in amorphous solid dispersions – Understanding the stabilizing potential
  Dr. Finn Bauer, MBA, Global Head of Solid Formulations R&D
  Dr. Benedict Benque, University of Technology, Graz, Austria
  Tuesday, November 6, 12:30 pm - 1:30 pm (Room 3)
• On-site manufacturing capsules with tunable release types and rates for accelerated pharmacokinetic screenings
  Derrick M Smith PhD, Associate Scientist, Merck and Co.
  Tuesday, November 6, 1:30 pm - 2:30 pm (Room 3)
• Formulation of 3D Printed Tablets for Rapid Drug Release by Fused Deposition Modeling
  Dr. Abu T. Serjuddin, Professor of Industrial Pharmacy, St. John’s University
  Tuesday, November 6, 2:30 pm - 3:30 pm (Room 3)
• Rapid Fire - Polyvinyl Alcohol for HME: Interactions between Polymer and Drug Substances
  Thomas Kipping, Head of Drug Carriers
  Monday, November 5, 3:15 pm (Room 146B)
• Rapid Fire - Next Generation Development Techniques for Chemically Defined Cell Culture Media
  Tom Boilard, Business Development Manager
  Tuesday, November 6, 4:00 pm (Room 145AB)
• Chalk Talk - Sustained Release Formulations of Peptides using the SynBiosys® Platform
  Dr. Tanja Henzler, Head of Liquid Formulation R&D
  Tuesday, November 6, 1:30 pm (Learning Lounge 2)

Take a Look at our Posters

• PVA in Sustained Release Matrix Tablets-Wet Granulated vs Direct Compression
  M1230-13-097   Nov 5, 12:30-1:30 pm
• Stability Study of Orally Disintegrating Tablets (ODT)
  M1430-11-084   Nov 5, 2:30-3:30 pm
• Polyvinyl Alcohol (PVA) in Amorphous Solid Dispersions – Understanding the Stabilizing Effect
  M1530-10-074   Nov 5, 3:30-4:30 pm
• The Screening of Pharmaceutical Impurities based on Certified Pharma Multi-Mix Reference Standard Solutions Following Monograph Methods
  T1030-07-051   Nov 6, 10:30-10:30 am
• Application of 3D Printing Technology and Quality by Design Approach for the Development of Age Appropriate Formulation
  W1030-09-070   Nov 7, 10:30-11:30 am